People: Biogaia AB (BIOGb.ST)
Mr. Peter Rothschild has been Chairman of the Board of Directors of BioGaia AB since April 25, 2018. He was Group President at the Company from March 1, 2016 till April 25, 2018. He no longer serves as Chief Executive Officer of the Company, effective as of March 1, 2016. He has held the position since 1996. He is also Founder and principal shareholder of the Company. He is Working Chairman of the subsidiaries BioGaia Production AB, BioGaia Pharma AB and CapAble AB as well as the associated company MetaboGen AB and The foundation to prevent antibiotic resistance. He also serves as Chairman of the Board of Directors of Infant Bacterial Therapeutics AB (IBT) AB and with board assignments in Glycom AB, Looft Industries AB and Stiftelsen Allbright. He holds a Master of Business Administration degree.
|Total Annual Compensation, SEK||2,326,000|
|Restricted Stock Award, SEK||--|
|Long-Term Incentive Plans, SEK||--|
|All Other, SEK||--|
|Fiscal Year Total, SEK||2,326,000|